Diagnóstico y tratamiento del déficit de Alfa-1-Antitripsina

por | Ago 25, 2010 | Protocolos de Actuación | 0 Comentarios

BIBLIOGRAFÍA

  1. ATS/ERS: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Resp Crit Care Med 2003; 168: 820-900.
  2. Miravitlles M, Vilà S, Torrella M, Balcells E, Rodríguez-Frías, de la Roza C, Jardí R, Vidal R. Influence of deficient alpha-1-antitrypsin phenotypes on clinical characteristics and severity of asthma in adults. Respir Med 2002; 96: 186-192.
  3. Rodríguez F, Jardí R, Costa X, Cotrina M, Galimany R, Vidal R, Miravitlles M. Rapid screening for alpha-1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood spots. Am J Respir Crit Care Med 2002; 166: 814-817.
  4. Luisetti M, Miravitlles M, Stockley RA. Alpha-1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. Eur Respir J 2002; 20: 1050-1056.
  5. Abbound RT, Ford GT, Chapman KR. Alpha-1 antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J 2001; 8: 81-88.
  6. Costa X, Jardí R, Rodríguez F, Miravitlles M, Cotrina M, Pascual C, Vidal R. Easy method for screening dried blood spot specimens on filter paper for alpha-1 antitrypsin deficiency. Eur Respir J 2000; 15: 1111-1115.
  7. Jardí R, Rodríguez-Frías F, Lopez-Talavera JC, Miravitlles M, Cotrina M, Costa X, Pascual C, Vidal R. Characterization of the new alpha-1-antitrypsin deficient PI M-type allele, PI Mvall d’hebron (Pro369—Ser). Human Hered 2000; 50; 320-321.
  8. Miravitlles M. Alpha-1-antitrypsin deficiency: epidemiology and prevalence. Respir Med 2000; 94 (Suppl C): S12-S15.
  9. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DCS, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, Vrooman HA, Reiber JHC, Hansen NC, Heckscher T, Viskum K, Stolk J. A Randomized Clinical Trial of 1-Antitrypsin Augmentation Therapy. Am. J. Respir. Crit. Care Med., 1999; 160: 1468-1472.
  10. Miravitlles M, Vidal R, Barros-Tizón JC, Bustamante A, España PP, Casas F, Martínez MT, Escudero C, Jardí R. Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Informe del registro nacional. Arch Bronconeumol 1999; 35: 446-454.
  11. Miravitlles M, de Gracia J, Rodrigo MJ, Cruz MJ, Vendrell M, Vidal R, Morell F. Specific antibody response against the 23-valent pneumococcal vaccine in patients with alpha-1-antitrypsin deficiency with and without bronchiectasis. Chest 1999; 116: 946-952.
  12. Alpha-1-Antitrypsin Deficiency Registry Study Group. Survival and FEV1 decline in individuals with severe deficiency of alpha-1-antitrypsin. Am J Respir Crit Care Med 1998;158:49-59.
  13. Miravitlles M. ¿Debemos administrar tratamiento sustitutivo a los pacientes con déficit de alfa-1-antitripsina? (editorial). Arch Bronconeumol 1998; 34: 109-111.
  14. Eden E, Mitchel D, Melhlman B, Khouli H, Nejat M, Grieco M, Turino G. Atopy, asthma and emphysema in patients with severe alpha 1 antitrypsine deficiency. Am J Respir Crit Care Med 1997; 156:68-74.
  15. Pierce JA. Alpha-1-Antitrypsin augmentation therapy (editorial). Chest 1997; 112, 4.
  16. Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, Konietzko N. Does alpha-1 antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe alpha-1 antitrypsin deficiency? Eur Respir J 1997;10:2260-3.
  17. Jardí R, Rodríguez-Frías F, Casas F, Cotrina M, Vidal R, Miravitlles M, Pascual C. Caracterización molecular de dos variantes deficitarias de la alfa-1-antitripsina: PI Mpalermo y PI Plovel. Med Clin (Barc) 1997; 109: 463-466.
  18. Mc Elvaney N, Stoller J, Buist A, Prakash U, Brantly M, Schluchter M, Crystal R and the alpha 1- antitrypsin deficiency registry study group. Baseline Charecteristics of enrollees in the national heart, lung and blood institute registry of alpha 1-antitrypsin deficiency. Chest 1997; 111:394-403.
  19. Stoller J, Buist A, Burrows B, et al. Quality control of spirometry testing in the registry of patients with severe alpha-1-antitrypsin deficiency. Chest 1997; 111: 899-909.
  20. Siofakos NM, Vermiere P, Pride NB, et al.. Optimal treatment and management of chronic obstructive pulmonary disease (COPD). Eur Resp J 1995; 8: 1398-1420.
  21. Blanco I, Fernández E, Rodríguez MC, Fernández A. Allelic frequency of the gene of alpha-1-antitrypsin in the general population in a county in Asturias. Med Clin (Barc) 1999; 113(10): 366-70.
  22. Miravitlles M, Vidal R, Barros-Tizón JC, Bustamante A, España PP, Casas F, Martínez MT, Escudero C, Jardí R. Usefulness of a national Registry of alpha-1-antitrypsin deficiency. The Spanish experience. Respir Med 1998; 92: 1181-1187
  23. Vidal R, Miravitlles M y Grupo de Estudio del déficit de alfa-1-antitripsina. Informe del Registro Español de Pacientes con déficit de alfa-1-antitripsina. Arch Bronconeumol 1995; 31: 299 -302.
  24. Alpha-1-Antitrypsin Deficiency Registry Study Group. A registry of patients with severe deficiency of alpha-1-antitrypsin: design and methods. Chest 1994; 106:1223-32.
  25. Rovner MS, Stoller JK. Therapy for Alpha-1 antitrypsin deficiency: rationale and strategic approach. Clin Pulm Med 1994; 1:135-143.
  26. Vidal R, Miravilles M, De Gracia X, Gallego B, Morell F. Tratamiento sustitutivo del enfisema por deficit de alfa-1- antitripsina. Med Clin (Barc) 1991;96:180-182
  27. American Thoracic Society. Guidelines for the approach to the patient with severe hereditayr alpha-1-antitrypsin deficiency. Am Rev Respir Dis. 1989; 140: 1494-1497
  28. Canadian Thoracic Society. Current status of alpha-1-antitrypsin replacement therapy: Recomendations for the management of patients with severe hereditary deficency. Am Rev Resp Dis 1989; 140:1494-1497
  29. Horowitz I, Schulman E. Alpha 1-PI for emphysema due to alpha 1 antitrypsin deficiency. Clinical Pharmacol 1989; 223-228
  30. Crystal R, Brantly M, Hubbard R, Curiel D, States D, Holmes M. The alpha 1- antitrypsin gene and its mutations. Clinical consequences and strtegies for therapy. chest 1989; 95:196-205
  31. Gadek JE, Klein HG, Holland PV, Cristal RG. Replacement therapy of alfa-1 antitrysin deficiency. J Clin Invest 1981; 68:1158-65
Páginas: 1 2 3 4 5 6 7 8 9
Cargando…